The UK’s pharmaceutical industry has published headline figures from its Disclosure UK scheme, showing payments from pharma to healthcare professionals increased in 2019.
The term “gate-keeper” implies only signatories are concerned with compliance with the ABPI Code of Practice, so we prefer the term “goalkeeper”; if the rest of the team are doing a poor jo
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.